The regulation of Cyp7a1 in this model of NAFLD (Fiorucci et al., 2021) is of relevance, since CYP7A1 is the rate-limiting enzyme in the synthesis of primary bile acids in the liver (Chiang and Ferrell 2020). This evidence concerns the gene CYP7A1 and metabolic dysfunction-associated steatotic liver disease.